本文基于2022年全球重磅炸弹药物销售数据，试图从数据角度发掘隐藏在重磅炸弹背后的逻辑。
Time：
2023-07-19 09:09
Author：
郭思周
FDA新法规：人体细胞和基因治疗产品的生产变更和可比性指南草案
由于人体细胞治疗1 或基因治疗2 (CGT) 产品的复杂性，生产变更的管理对这些产品具有诸多挑战。
Time：
2023-07-18 10:05
Author：
Zoey Z
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务